The rapid progress in gene therapy gives rise to critical ethical concerns about informed consent, safety, and accessibility. The ethical implications of modifying human DNA will be discussed, focusing on bodily versus germline editing. The challenges include navigating regulatory environments, resolving public concerns about genetic changes, and maintaining fair access to medicines. Including stakeholders in discussions—such as ethicists, healthcare providers, and patients—can aid in the creation of complete suggestions that strike a balance between innovation and moral obligation.